Clinical trial
Assessment of Allogeneic Hematopoietic Cell Transplantation in Medicare Beneficiaries With Multiple Myeloma: A Study to Develop Evidence of Effectiveness for the Centers for Medicare and Medicaid Services (CMS)
NCT03127761 is registered in ClinicalTrials.gov with Center for International Blood and Marrow Transplant Research as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Assessment of Allogeneic Hematopoietic Cell Transplantation in Medicare Beneficiaries With Multiple Myeloma: A Study to Develop Evidence of Effectiveness for the Centers for Medicare and Medicaid Services (CMS)
- Lead sponsor
- Center for International Blood and Marrow Transplant Research
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- July 25, 2017
- Completion date
- April 30, 2028
- Enrollment
- 544 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.